|Articles|May 1, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
FDA Advisory Committee Backs RP1 for Advanced Melanoma
2
Living With Lung Cancer, Not Dying From It: One Survivor's Story of Hope
3
Same-Day Discharge and Single-Incision Surgery Are Changing Rectal Cancer Care
4
Oncology Researcher Brings Science, Compassion and Personal Loss to Cancer Care
5